|
Online Database of Chemicals from Around the World | Search | Submit | Advertise | |
Home >> Chemical Listing >> STA-9584>> Market Analysis Reports |
Market Analysis Reports of STA-9584 |
|
Synta Pharmaceuticals Corp. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis ... program in oncology. STA-9090, Hsp90 inhibitor: STA-9090, the ... elesclomol in metastatic melanoma. STA-9584, vascular disrupting agent: STA-9584 is, the companys ... Apilimod (IL-12 and IL-23 inhibitor): Apilimod (STA-5326) is an orally administered, small ... |